Standard Therapy Given With or Without Combination Chemotherapy in Treating Patients With Non-small Cell Lung Cancer

Sponsor
National Cancer Institute (NCI)
Study ID
NCT00003240
Phase
PHASE3
Status
Unknown

Conditions

Eligibility Criteria

Sex
ALL
Age
18 Years - N/A
Healthy Volunteers
Not accepted

Interventions

  • cisplatin — DRUG
  • ifosfamide — DRUG
  • mitomycin C — DRUG
  • vinblastine sulfate — DRUG
  • vindesine — DRUG
  • vinorelbine tartrate — DRUG
  • conventional surgery — PROCEDURE
  • radiation therapy — RADIATION

Study Details

RATIONALE: Drugs used in chemotherapy use different ways to stop tumor cells from dividing so they stop growing or die. It is not known whether giving chemotherapy in addition to standard therapy is a more effective treatment for lung cancer. PURPOSE: Randomized phase III trial to compare the effectiveness of standard therapy given with or without combination chemotherapy in treating patients with non-small cell lung cancer.

Key Dates

Start date
Oct 31, 1995
Status verified
May 2007

Study Design

Enrollment
1,800 participants (estimated)
Allocation
RANDOMIZED
Primary purpose
TREATMENT

Related Studies